abstract |
The present invention relates to the crystallinity of 5- (2-{[6- (2,2-difluoro-2-phenylethoxy) hexyl] amino} -1-hydroxyethyl) -8-hydroxyquinolin-2 (1H) -one. The present invention relates to mononapadisilate and / or heminapadisylate, and pharmaceutically acceptable solvates thereof. |